| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advanced Lung Cancer Inflammation Index, a New Prognostic Score, Predicts Outcome in Patients With Small-Cell Lung Cancer
|
He, Xiaobo
|
|
2015
|
16 |
6 |
p. e165-e171
nvt p.
|
artikel
|
| 2 |
Angiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24
|
Bar, Jair
|
|
2015
|
16 |
6 |
p. e189-e201
nvt p.
|
artikel
|
| 3 |
A Randomized, Open-Label Phase II Trial of Volasertib as Monotherapy and in Combination With Standard-Dose Pemetrexed Compared With Pemetrexed Monotherapy in Second-Line Treatment for Non–Small-Cell Lung Cancer
|
Ellis, Peter M.
|
|
2015
|
16 |
6 |
p. 457-465
9 p.
|
artikel
|
| 4 |
A Retrospective Study of Stage I to IIIa Lung Adenocarcinoma After Resection: What Is the Optimal Adjuvant Modality for Patients With an EGFR Mutation?
|
Lv, Chao
|
|
2015
|
16 |
6 |
p. e173-e181
nvt p.
|
artikel
|
| 5 |
A Review of the Place and Role of Radiotherapy in Thymoma
|
Lombe, Dorothy C.
|
|
2015
|
16 |
6 |
p. 406-412
7 p.
|
artikel
|
| 6 |
CHAMP: A Phase II Study of Panitumumab With Pemetrexed and Cisplatin Versus Pemetrexed and Cisplatin in the Treatment of Patients With Advanced-Stage Primary Nonsquamous Non–Small-Cell Lung Cancer With Particular Regard to the KRAS Status
|
Schuette, Wolfgang
|
|
2015
|
16 |
6 |
p. 447-456
10 p.
|
artikel
|
| 7 |
Cisplatin, Etoposide, and Bevacizumab Regimen Followed by Oral Etoposide and Bevacizumab Maintenance Treatment in Patients With Extensive-Stage Small Cell Lung Cancer: A Single-Institution Experience
|
Petrioli, Roberto
|
|
2015
|
16 |
6 |
p. e229-e234
nvt p.
|
artikel
|
| 8 |
Classification and Reporting of Late Radiographic Changes After Lung Stereotactic Body Radiotherapy: Proposing a New System
|
Raziee, Hamid
|
|
2015
|
16 |
6 |
p. e245-e251
nvt p.
|
artikel
|
| 9 |
Defining the High-Risk Population for Mortality After Resection of Early Stage NSCLC
|
Husain, Zain A.
|
|
2015
|
16 |
6 |
p. e183-e187
nvt p.
|
artikel
|
| 10 |
Editorial Board
|
|
|
2015
|
16 |
6 |
p. A1-
1 p.
|
artikel
|
| 11 |
Estimated Creatinine Clearance Rate Is Associated With the Treatment Effectiveness and Toxicity of Pemetrexed As Continuation Maintenance Therapy for Advanced Nonsquamous Non–Small-Cell Lung Cancer
|
Chen, Chung-Yu
|
|
2015
|
16 |
6 |
p. e131-e140
nvt p.
|
artikel
|
| 12 |
FDG-PET Predicts Pain Response and Local Control in Palliative Radiotherapy With or Without Systemic Treatment in Patients With Bone Metastasis From Non–small-cell Lung Cancer
|
Zhao, Fen
|
|
2015
|
16 |
6 |
p. e111-e119
nvt p.
|
artikel
|
| 13 |
First Reported Case of Unexpected Response to an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in the I744M Uncommon EGFR Mutation
|
Kempf, Emmanuelle
|
|
2015
|
16 |
6 |
p. e259-e261
nvt p.
|
artikel
|
| 14 |
miR Profiling Identifies Cyclin-Dependent Kinase 6 Downregulation as a Potential Mechanism of Acquired Cisplatin Resistance in Non–Small-Cell Lung Carcinoma
|
Bar, Jair
|
|
2015
|
16 |
6 |
p. e121-e129
nvt p.
|
artikel
|
| 15 |
Modern Treatments in Advanced Non–Small-Cell Lung Cancer: Temporal Trends and Effect on Survival. A French Population-Based Study
|
Carpentier, Olivier
|
|
2015
|
16 |
6 |
p. 496-506
11 p.
|
artikel
|
| 16 |
Outcomes of Modestly Hypofractionated Radiation for Lung Tumors: Pre- and Mid-Treatment Positron Emission Tomography-Computed Tomography Metrics as Prognostic Factors
|
Harris, Jeremy P.
|
|
2015
|
16 |
6 |
p. 475-485
11 p.
|
artikel
|
| 17 |
Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective Analysis
|
Genestreti, Giovenzio
|
|
2015
|
16 |
6 |
p. e223-e228
nvt p.
|
artikel
|
| 18 |
Plasma EGFR Mutation Detection Associated With Survival Outcomes in Advanced-Stage Lung Cancer
|
Lam, David C.L.
|
|
2015
|
16 |
6 |
p. 507-513
7 p.
|
artikel
|
| 19 |
Preliminary Safety, Pharmacokinetics, and Efficacy of Regorafenib, Cisplatin, and Pemetrexed in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancers
|
Hellmann, Matthew D.
|
|
2015
|
16 |
6 |
p. 514-522
9 p.
|
artikel
|
| 20 |
Primary Treatment Options for High-Risk/Medically Inoperable Early Stage NSCLC Patients
|
Jones, Guy C.
|
|
2015
|
16 |
6 |
p. 413-430
18 p.
|
artikel
|
| 21 |
Prognostic Factors for Survival After Recurrence in Patients With Completely Resected Lung Adenocarcinoma: Important Roles of Epidermal Growth Factor Receptor Mutation Status and the Current Staging System
|
Kudo, Yujin
|
|
2015
|
16 |
6 |
p. e213-e221
nvt p.
|
artikel
|
| 22 |
Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non–Small-Cell Lung Cancer After Curative Resection
|
Yoo, Changhoon
|
|
2015
|
16 |
6 |
p. e203-e212
nvt p.
|
artikel
|
| 23 |
Quercetin Enhances Chemosensitivity to Gemcitabine in Lung Cancer Cells by Inhibiting Heat Shock Protein 70 Expression
|
Lee, Seung Hyeun
|
|
2015
|
16 |
6 |
p. e235-e243
nvt p.
|
artikel
|
| 24 |
Ratio of Lymph Node to Primary Tumor SUV on PET/CT Accurately Predicts Nodal Malignancy in Non–Small-Cell Lung Cancer
|
Mattes, Malcolm D.
|
|
2015
|
16 |
6 |
p. e253-e258
nvt p.
|
artikel
|
| 25 |
Semiquantitative Computed Tomography Characteristics for Lung Adenocarcinoma and Their Association With Lung Cancer Survival
|
Wang, Hua
|
|
2015
|
16 |
6 |
p. e141-e163
nvt p.
|
artikel
|
| 26 |
Stromal Caveolin-1 Is Associated With Response and Survival in a Phase II Trial of nab-Paclitaxel With Carboplatin for Advanced NSCLC Patients
|
Bertino, Erin M.
|
|
2015
|
16 |
6 |
p. 466-474.e4
4.739535E6 p.
|
artikel
|
| 27 |
Table of Contents
|
|
|
2015
|
16 |
6 |
p. A6-A14
nvt p.
|
artikel
|
| 28 |
Therapeutic Potential of Denosumab in Patients With Lung Cancer: Beyond Prevention of Skeletal Complications
|
De Castro, Javier
|
|
2015
|
16 |
6 |
p. 431-446
16 p.
|
artikel
|
| 29 |
Treatment of Unfit Patients With Advanced Non–Small-Cell Lung Cancer: Definition Criteria According an Expert Panel
|
De Marinis, Filippo
|
|
2015
|
16 |
6 |
p. 399-405
7 p.
|
artikel
|
| 30 |
Treatment Patterns and Health Resource Utilization Among Patients Diagnosed With Early Stage Resected Non–Small Cell Lung Cancer at US Community Oncology Practices
|
Buck, Philip O.
|
|
2015
|
16 |
6 |
p. 486-495
10 p.
|
artikel
|
Tijdschrift beschrijving